NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome

NCT ID: NCT02570516

Last Updated: 2019-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

141 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-30

Study Completion Date

2018-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares two colonoscopy techniques (with Narrow Band Imaging versus with indigo carmine chromoendoscopy) in patients having Lynch Syndrome

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Chromoendoscopy using indigo carmine dye is recommended every 1 to 2 years in patients having Lynch Syndrome (LS). However, it is a time-consuming procedure, requiring a prior learning and has an additional cost, the reason why it is not yet systematically practiced in all endoscopy centers. The "Narrow Band Imaging" (NBI) is a recent virtual chromoendoscopy technique using optical filters at the light source of the endoscope to highlight the vascular structures of the mucosa by pressing a button. NBI is currently used to better characterize dysplasia lesions in the esophageal, gastric, and colon mucosa. A new generation (3rd generation) of NBI is currently available on some endoscopes, it can deliver more brightness and contrast, and could allow for better detection of flat lesions. Until today, no study has directly compared colonic chromoendoscopy with Indigo carmine to virtual chromoendoscopy with NBI (3rd generation) in LS patients. The hypothesis that this research aims to verify is that the new generation NBI system might do at least as well as indigo carmine in colonic adenoma detection in LS. This study aims to compare colonoscopy with virtual chromoendoscopy using 3rd generation NBI system to chromoendoscopy with indigo carmine in LS patients, in a back-to-back, prospective non inferiority design, in which all patients will have both techniques in the following order: NBI first followed by Indigo carmine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lynch Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Indigo carmine colonoscopy

Colonoscopy using indigo carmine is performed in second place

Group Type ACTIVE_COMPARATOR

Colonoscopy

Intervention Type PROCEDURE

A double colonoscopy is performed in a back-to-back design using NBI chromoendoscopy then indigo carmine in each patient.

NBI colonoscopy

Colonoscopy using NBI is performed in first place

Group Type EXPERIMENTAL

Colonoscopy

Intervention Type PROCEDURE

A double colonoscopy is performed in a back-to-back design using NBI chromoendoscopy then indigo carmine in each patient.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Colonoscopy

A double colonoscopy is performed in a back-to-back design using NBI chromoendoscopy then indigo carmine in each patient.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Lynch Syndrome with an identified mutation in one of the genes MutL Homolog 1 (MLH1), MutL Homolog 2 (MLH2), MutS homolog6 (MSH6), PMS2 or epithelial cellular adhesion molecule (EpCAM)
* Age between 18 and 80
* Indication of a screening colonoscopy

Exclusion Criteria

* Any sign of intestinal occlusion contra-indicating bowel preparation
* History of total or subtotal colectomy
* Any serious medical condition contra-indicating colonoscopy under general anesthesia
* Pregnant or breast feeding women
* Any coagulation disorder contra-indicating biopsies or endoscopic resections
* Any history of hypersensitivity to indigo carmine
* Adults subject to a legal protection measure (guardianship or curatorship)
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

ARC Foundation for Cancer Research

OTHER

Sponsor Role collaborator

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

CHRISTOPHE CELLIER, MD, PHD

Role: PRINCIPAL_INVESTIGATOR

Hopital europeen Georges Pompidou

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

HCL - Hôpital Edouard-Herriot

Lyon, Auvergne-Rhône-Alpes, France

Site Status

CHRU de Tours - Hôpital Trousseau

Chambray-lès-Tours, Centre-Val de Loire, France

Site Status

CHU Nantes - Hôtel-Dieu

Nantes, Pays de la Loire Region, France

Site Status

AP-HP - Hôpital Européen Georges-Pompidou

Paris, , France

Site Status

AP-HP - Hôpital Saint-Antoine

Paris, Île-de-France Region, France

Site Status

AP-HP - Hôpital Cochin

Paris, Île-de-France Region, France

Site Status

Institut Gustave-Roussy

Villejuif, Île-de-France Region, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Cellier C, Perrod G, Colas C, Dhooge M, Saurin JC, Lecomte T, Coron E, Rahmi G, Savale C, Chaussade S, Bellanger J, Dray X, Benech N, Le Rhun M, Barbieux JP, Pereira H, Chatellier G, Samaha E. Back-to-Back Comparison of Colonoscopy With Virtual Chromoendoscopy Using a Third-Generation Narrow-Band Imaging System to Chromoendoscopy With Indigo Carmine in Patients With Lynch Syndrome. Am J Gastroenterol. 2019 Oct;114(10):1665-1670. doi: 10.14309/ajg.0000000000000386.

Reference Type DERIVED
PMID: 31498154 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2015-A00552-47

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

P140108

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Predicting NOM Failure in Bowel Obstruction
NCT06711107 ACTIVE_NOT_RECRUITING